Cite
HARVARD Citation
Chaparro, M. et al. (n.d.). P666 Long-term effectiveness and safety of vedolizumab (VDZ) in inflammatory bowel disease (IBD): Results from the Spanish ENEIDA Registry. Journal of Crohn's and colitis. pp. S447-S448. [Online].